These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25633676)

  • 1. Corpus callosum atrophy rate in mild cognitive impairment and prodromal Alzheimer's disease.
    Elahi S; Bachman AH; Lee SH; Sidtis JJ; Ardekani BA;
    J Alzheimers Dis; 2015; 45(3):921-31. PubMed ID: 25633676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corpus callosum atrophy associated with the degree of cognitive decline in patients with Alzheimer's dementia or mild cognitive impairment: a meta-analysis of the region of interest structural imaging studies.
    Wang XD; Ren M; Zhu MW; Gao WP; Zhang J; Shen H; Lin ZG; Feng HL; Zhao CJ; Gao K
    J Psychiatr Res; 2015 Apr; 63():10-9. PubMed ID: 25748753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Callosal circularity as an early marker for Alzheimer's disease.
    Van Schependom J; Niemantsverdriet E; Smeets D; Engelborghs S
    Neuroimage Clin; 2018; 19():516-526. PubMed ID: 29984160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H; Teipel SJ; Alexander GE; Pogarell O; Rapoport SI; Möller HJ
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deformation-based Statistical Shape Analysis of the Corpus Callosum in Mild Cognitive Impairment and Alzheimer's Disease.
    Jiang Z; Yang H; Tang X
    Curr Alzheimer Res; 2018; 15(12):1151-1160. PubMed ID: 30101708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corpus callosum shape and size changes in early Alzheimer's disease: a longitudinal MRI study using the OASIS brain database.
    Bachman AH; Lee SH; Sidtis JJ; Ardekani BA
    J Alzheimers Dis; 2014; 39(1):71-8. PubMed ID: 24121963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the corpus callosum in patients with Alzheimer's disease: Deep learning-based assessment.
    Kamal S; Park I; Kim YJ; Kim YJ; Lee U
    PLoS One; 2021; 16(12):e0259051. PubMed ID: 34941878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study.
    Di Paola M; Di Iulio F; Cherubini A; Blundo C; Casini AR; Sancesario G; Passafiume D; Caltagirone C; Spalletta G
    Neurology; 2010 Apr; 74(14):1136-42. PubMed ID: 20368633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease.
    Thomann PA; Wustenberg T; Pantel J; Essig M; Schroder J
    Dement Geriatr Cogn Disord; 2006; 21(4):215-20. PubMed ID: 16415572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.
    Wang PJ; Saykin AJ; Flashman LA; Wishart HA; Rabin LA; Santulli RB; McHugh TL; MacDonald JW; Mamourian AC
    Neurobiol Aging; 2006 Nov; 27(11):1613-7. PubMed ID: 16271806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corpus callosum atrophy and cognitive decline in early Alzheimer's disease: longitudinal MRI study.
    Zhu M; Wang X; Gao W; Shi C; Ge H; Shen H; Lin Z
    Dement Geriatr Cogn Disord; 2014; 37(3-4):214-22. PubMed ID: 24193144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease.
    Cavedo E; Suppa P; Lange C; Opfer R; Lista S; Galluzzi S; Schwarz AJ; Spies L; Buchert R; Hampel H; ;
    J Alzheimers Dis; 2017; 60(1):151-164. PubMed ID: 28777748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corpus callosum shape changes in early Alzheimer's disease: an MRI study using the OASIS brain database.
    Ardekani BA; Bachman AH; Figarsky K; Sidtis JJ
    Brain Struct Funct; 2014 Jan; 219(1):343-52. PubMed ID: 23322167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging.
    Janowsky JS; Kaye JA; Carper RA
    J Am Geriatr Soc; 1996 Jul; 44(7):798-803. PubMed ID: 8675927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corpus Callosum Structure is Topographically Correlated with the Early Course of Cognition and Depression in Alzheimer's Disease.
    Di Paola M; Phillips O; Orfei MD; Piras F; Cacciari C; Caltagirone C; Spalletta G
    J Alzheimers Dis; 2015; 45(4):1097-108. PubMed ID: 25649657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the size and area of the corpus callosum with the Osiris method in Alzheimer's disease.
    Kabay SC; Gulbandilar E; Ozden H; Ozbag D; Guven G; Adapinar B; Durmaz R
    Neurodegener Dis; 2009; 6(4):148-53. PubMed ID: 19521062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting progression from mild cognitive impairment to Alzheimer's disease using longitudinal callosal atrophy.
    Lee SH; Bachman AH; Yu D; Lim J; Ardekani BA
    Alzheimers Dement (Amst); 2016; 2():68-74. PubMed ID: 27239537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.